PURPOSE: Accumulating evidences implicate the selenium-containing cytosolic glutathione peroxidase, GPx-1, as a determinant of cancer risk and a mediator of the chemopreventive properties of selenium. Since the identification of a well-characterized functional polymorphism named Pro198Leu (rs1050450 C>T) in GPx-1, abundant studies have evaluated the association between Pro198Leu polymorphism and tumor risk in diverse population. But, the available results are conflicting. METHODS: To derive a more precise estimation, we performed a meta-analysis based on 14,372 cases with different tumor types and 18,081 controls from 31 published case-control studies. Published literature from PubMed was retrieved. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to estimate the strength of the association. RESULTS: Overall, the results indicated that individuals who carried variant Leu allele (Pro/Leu and Leu/Leu) were associated with an increased cancer risk [odds ratio (OR) = 1.12, 95% confidence interval (CI) = 1.02-1.23] in a dominant genetic model. In further subgroup analyses, the increased risk of cancer was observed in subgroup of Asians and sample size more than 500 subjects. CONCLUSION: These results suggest that the GPx-1 Pro198Leo polymorphism contributes to cancer susceptibility through a disturbed antioxidant balance.
PURPOSE: Accumulating evidences implicate the selenium-containing cytosolic glutathione peroxidase, GPx-1, as a determinant of cancer risk and a mediator of the chemopreventive properties of selenium. Since the identification of a well-characterized functional polymorphism named Pro198Leu (rs1050450 C>T) in GPx-1, abundant studies have evaluated the association between Pro198Leu polymorphism and tumor risk in diverse population. But, the available results are conflicting. METHODS: To derive a more precise estimation, we performed a meta-analysis based on 14,372 cases with different tumor types and 18,081 controls from 31 published case-control studies. Published literature from PubMed was retrieved. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to estimate the strength of the association. RESULTS: Overall, the results indicated that individuals who carried variant Leu allele (Pro/Leu and Leu/Leu) were associated with an increased cancer risk [odds ratio (OR) = 1.12, 95% confidence interval (CI) = 1.02-1.23] in a dominant genetic model. In further subgroup analyses, the increased risk of cancer was observed in subgroup of Asians and sample size more than 500 subjects. CONCLUSION: These results suggest that the GPx-1Pro198Leo polymorphism contributes to cancer susceptibility through a disturbed antioxidant balance.
Authors: D Ratnasinghe; J A Tangrea; M R Andersen; M J Barrett; J Virtamo; P R Taylor; D Albanes Journal: Cancer Res Date: 2000-11-15 Impact factor: 12.701
Authors: Gitte Ravn-Haren; Anja Olsen; Anne Tjønneland; Lars O Dragsted; Bjørn A Nexø; Håkan Wallin; Kim Overvad; Ole Raaschou-Nielsen; Ulla Vogel Journal: Carcinogenesis Date: 2005-11-14 Impact factor: 4.944
Authors: Tracy J Lightfoot; Christine F Skibola; Alex G Smith; Matthew S Forrest; Peter J Adamson; Gareth J Morgan; Paige M Bracci; Eve Roman; Martyn T Smith; Elizabeth A Holly Journal: Haematologica Date: 2006-09 Impact factor: 9.941
Authors: Albert Rosenberger; Thomas Illig; Katrin Korb; Norman Klopp; Vera Zietemann; Gabi Wölke; Eckart Meese; Gerhard Sybrecht; Florian Kronenberg; Matthias Cebulla; Maria Degen; Peter Drings; Andreas Gröschel; Nikolaus Konietzko; Karsten Grosse Kreymborg; Karl Häussinger; Gerd Höffken; Bettina Jilge; You-Dschun Ko; Harald Morr; Christine Schmidt; E-Wilhelm Schmidt; Dagmar Täuscher; Heike Bickeböller; H-Erich Wichmann Journal: BMC Cancer Date: 2008-02-25 Impact factor: 4.430
Authors: Dede N Ekoue; Soumen Bera; Emmanuel Ansong; Peter C Hart; Sofia Zaichick; Frederick E Domann; Marcelo G Bonini; Alan M Diamond Journal: Free Radic Res Date: 2017-07-04
Authors: Leigh A Johnson; Jack A Phillips; Cortney Mauer; Melissa Edwards; Valerie Hobson Balldin; James R Hall; Robert Barber; Tori L Conger; Eric J Ho; Sid E O'Bryant Journal: BMC Psychiatry Date: 2013-01-04 Impact factor: 3.630
Authors: Thierry Habyarimana; Youssef Bakri; Pacifique Mugenzi; Jean Baptiste Mazarati; Mohammed Attaleb; Mohammed El Mzibri Journal: Mol Genet Genomic Med Date: 2018-02-06 Impact factor: 2.183